tradingkey.logo
๎™

Metsera Inc

MTSR
70.500USD
0.000
์ข…๊ฐ€ย 12/31, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
7.41B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ Metsera Inc ํšŒ์‚ฌ

Metsera, Inc. is a clinical-stage biopharmaceutical company, which is developing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies. The Company uses its proprietary MINT peptide library of nutrient stimulated hormone (NuSH) analog peptides alongside its half-life augmentation by lipid optimization (HALO) half-life extending platform and its MOMENTUM oral NuSH analog peptide delivery platform to deliver differentiated product candidates. Its product pipeline includes MET-097i, MET-233i, MET-233i + MET-097i, MET-097o/MET-224o, MET-002o, MET-034i, MET-067i, and MET-815i. The Company's additional pipeline includes MET-815i, MET-AMYo, MET-034i, MET-067i and MET-PYYi. MET-097i, its advanced product candidate, is a fully biased, monthly, subcutaneously injectable ultra-long acting GLP-1 RA. MET-233i is a subcutaneously injectable ultra-long-acting amylin analog, with enhanced solubility and miscibility with its other NuSH analog peptides.

Metsera Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ MTSR
ํšŒ์‚ฌ ์ด๋ฆ„Metsera Inc
์ƒ์žฅ์ผJan 31, 2025
CEOMr. Christopher Whitten Bernard
์ง์› ์ˆ˜74
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒJan 31
์ฃผ์†Œ3 World Trade Center
๋„์‹œNEW YORK
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ Global Select Consolidated
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ10007
์ „ํ™”12127846595
์›น์‚ฌ์ดํŠธhttps://metsera.com/
์ข…๋ชฉ ์ฝ”๋“œ MTSR
์ƒ์žฅ์ผJan 31, 2025
CEOMr. Christopher Whitten Bernard

Metsera Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
,
,
--
--
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
,
,
--
--

์ˆ˜์ต ๋ถ„์„

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Nov 17
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Nov 17
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Fidelity Management & Research Company LLC
13.18%
The Vanguard Group, Inc.
5.52%
Janus Henderson Investors
5.08%
Alphabet, Inc.
3.59%
VR Adviser, LLC
3.56%
๊ธฐํƒ€
69.06%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Fidelity Management & Research Company LLC
13.18%
The Vanguard Group, Inc.
5.52%
Janus Henderson Investors
5.08%
Alphabet, Inc.
3.59%
VR Adviser, LLC
3.56%
๊ธฐํƒ€
69.06%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Investment Advisor
30.74%
Investment Advisor/Hedge Fund
14.21%
Venture Capital
10.07%
Hedge Fund
5.48%
Research Firm
0.82%
Bank and Trust
0.38%
Pension Fund
0.09%
Insurance Company
0.02%
๊ธฐํƒ€
38.19%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 5 hours ago
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: 5 hours ago
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
256
65.13M
61.80%
-25.57M
2025Q3
191
90.76M
86.24%
+3.57M
2025Q2
133
95.51M
90.92%
+74.51M
2025Q1
104
95.08M
90.50%
+81.16M

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Fidelity Management & Research Company LLC
13.89M
13.18%
-1.87M
-11.84%
Sep 30, 2025
The Vanguard Group, Inc.
5.82M
5.52%
+4.33M
+291.48%
Sep 30, 2025
Janus Henderson Investors
5.35M
5.08%
+1.96M
+57.99%
Sep 30, 2025
Alphabet, Inc.
3.78M
3.59%
-1.18M
-23.75%
Sep 30, 2025
VR Adviser, LLC
3.75M
3.56%
--
--
Sep 30, 2025
Wellington Management Company, LLP
3.66M
3.47%
+232.03K
+6.77%
Sep 30, 2025
SB Global Advisers Ltd
3.65M
3.47%
-1.17M
-24.17%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.51M
3.33%
+2.38M
+210.61%
Sep 30, 2025
HBK Investments, L.P.
3.20M
3.04%
+3.20M
--
Sep 30, 2025
State Street Investment Management (US)
2.51M
2.38%
+1.91M
+318.37%
Sep 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
First Trust Merger Arbitrage ETF
22.46%
Roundhill GLP-1 & Weight Loss ETF
4.57%
ProShares Merger ETF
3.14%
ALPS Medical Breakthroughs ETF
2.73%
Amplify Weight Loss Drug & Treatment ETF
1.68%
Direxion Daily S&P Biotech Bull 3X Shares
0.98%
Pacer WealthShield ETF
0.25%
BNY Mellon US Small Cap Core Equity ETF
0.17%
First Trust US Equity Opportunities ETF
0.15%
Global X Russell 2000 ETF
0.12%
๋” ๋ณด๊ธฐ
First Trust Merger Arbitrage ETF
๋น„์œจ22.46%
Roundhill GLP-1 & Weight Loss ETF
๋น„์œจ4.57%
ProShares Merger ETF
๋น„์œจ3.14%
ALPS Medical Breakthroughs ETF
๋น„์œจ2.73%
Amplify Weight Loss Drug & Treatment ETF
๋น„์œจ1.68%
Direxion Daily S&P Biotech Bull 3X Shares
๋น„์œจ0.98%
Pacer WealthShield ETF
๋น„์œจ0.25%
BNY Mellon US Small Cap Core Equity ETF
๋น„์œจ0.17%
First Trust US Equity Opportunities ETF
๋น„์œจ0.15%
Global X Russell 2000 ETF
๋น„์œจ0.12%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Metsera Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Metsera Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
Fidelity Management & Research Company LLC๋Š” 13.89M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 13.18%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
The Vanguard Group, Inc.๋Š” 5.82M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 5.52%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Janus Henderson Investors๋Š” 5.35M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 5.08%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Alphabet, Inc.๋Š” 3.78M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 3.59%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
VR Adviser, LLC๋Š” 3.75M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 3.56%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

Metsera Inc์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Metsera Inc์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.
Janus Henderson Investors์ž…๋‹ˆ๋‹ค.

Metsera Inc(MTSR)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q4 ๊ธฐ์ค€์œผ๋กœ, Metsera Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 256๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 65.13M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 61.80%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q3 ๋Œ€๋น„ -24.44% ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

Metsera Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
-- ๊ธฐ์ค€, Metsera Inc์˜ -- ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ --๋กœ ์ „์ฒด ๋งค์ถœ์˜ --%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™